Article Versions Notes

Woelber L, Hampl M, Eulenburg Cz, Prieske K, Hambrecht J, Fuerst S, Klapdor R, Heublein S, Gass P, Rohner A, et al. Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study. Cancers. 2022; 14(2):418. https://doi.org/10.3390/cancers14020418

Woelber, Linn, Monika Hampl, Christine zu Eulenburg, Katharina Prieske, Johanna Hambrecht, Sophie Fuerst, Ruediger Klapdor, Sabine Heublein, Paul Gass, Annika Rohner, and et al. 2022. "Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study" Cancers 14, no. 2: 418. https://doi.org/10.3390/cancers14020418

Woelber, L., Hampl, M., Eulenburg, C. z., Prieske, K., Hambrecht, J., Fuerst, S., Klapdor, R., Heublein, S., Gass, P., Rohner, A., Canzler, U., Becker, S., Bommert, M., Bauerschlag, D., Denecke, A., Hanker, L., Runnebaumn, I., Forner, D. M., Schochter, F., ... Jaeger, A. (2022). Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study. Cancers, 14(2), 418. https://doi.org/10.3390/cancers14020418